Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Sponsor
UNICANCER
Study ID
NCT00066274
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • FOLFIRI regimen — DRUG
  • FOLFOX regimen — DRUG
  • fluorouracil — DRUG
  • irinotecan hydrochloride — DRUG
  • leucovorin calcium — DRUG
  • oxaliplatin — DRUG

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving the drugs in different combinations may kill more tumor cells. PURPOSE: This randomized phase II trial is studying combination chemotherapy containing irinotecan and oxaliplatin to see how well it works compared to two standard combination chemotherapy regimens in treating patients with unresectable metastatic colorectal cancer.

Key Dates

Start date
Jul 23, 2002
Status verified
Feb 2021
Primary completion
Nov 4, 2005
Completion
Apr 1, 2007

Study Design

Allocation
RANDOMIZED
Primary purpose
TREATMENT

Related Studies